The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Thymoquinone, as an anticancer molecule: from basic research to clinical investigation
Open accessAbstract
// Md. Asaduzzaman Khan 1, 2 , Mousumi Tania 3 , Shangyi Fu 4 and Junjiang Fu 1 1 Key Laboratory of Epigenetics and Oncology, The Research Center for Preclinical Medicine, Southwest Medical University, Luzhou, Sichuan, China 2 Faculty of Applied Sciences, Ton Duc Thang University, Ho Chi Minh City, Vietnam 3 Division of Computer Aided Drug Design, The Red-Green Computing Centre, Dhaka, Bangladesh 4 The Honors College, University of Houston, Houston, Texas, United States Correspondence to: Junjiang Fu, email: fujunjiang@swmu.edu.cn , fujunjiang@hotmail.com Md. Asaduzzaman Khan, email: asadkhan@swmu.edu.cn , asadkhanbmj@yahoo.com Keywords: Nigella sativa, thymoquinone, anticancer, mouse model, clinical studies Received: March 13, 2017 Accepted: April 05, 2017 Published: April 18, 2017 ABSTRACT Thymoquinone is an anticancer phytochemical commonly found in black cumin. In this review, we discuss the potential of thymoquinone as anticancer molecule, its mechanism of action and future usage in clinical applications. Thymoquinone exhibits anticancer activity via numerous mechanisms of action, specifically by showing selective antioxidant and oxidant activity, interfering with DNA structure, affecting carcinogenic signaling molecules/pathways and immunomodulation. In vitro activity of thymoquinone has been further implicated in animal models of cancer; however, no clinical application has been proven yet. This is the optimum time to focus on clinical trials for developing thymoquinone as a future drug in cancer therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer statistics in China, 2015
Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X. Q., & He, J. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21338 · Cited by 17,038
Cancer treatment and survivorship statistics, 2016
Miller, K. D., Siegel, R. L., Lin, C. C., Mariotto, A. B., Kramer, J. L., Rowland, J. H., Stein, K. D., Alteri, R., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21349 · Cited by 6,066
Cited by
Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements
Aggarwal, V., Tuli, H., Varol, A., Thakral, F., Yerer, M., Sak, K., Varol, M., Jain, A., Khan, M., & Sethi, G. (2019) · Biomolecules · doi:10.3390/biom9110735 · Cited by 1,221
Shahein, S. A., Aboul-Enein, A. M., Higazy, I. M., Abou-Elella, F., Lojkowski, W., Ahmed, E. R., Mousa, S. A., & AbouAitah, K. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s206899 · Cited by 52
Metadata
- Authors
- Asaduzzaman Khan, M., Tania, M., Fu, S., & Fu, J.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2017-04-18
- Volume
- 8
- Issue
- 31
- Pages
- 51907-51919
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2606695026
- Cited by
- 249
- References
- 2
- FWCI
- 26.02
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Thymoquinone, as an anticancer molecule: from basic research to clinical investigation. https://app.cochat.ai/papers/10.18632/oncotarget.17206
- The paper
- Asaduzzaman Khan, M., Tania, M., Fu, S., & Fu, J. (2017). Thymoquinone, as an anticancer molecule: from basic research to clinical investigation. Oncotarget. https://doi.org/10.18632/oncotarget.17206
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.